AMENDMENT TO 8% PROMISSORY NOTE8% Promissory Note • April 17th, 2018 • Creative Medical Technology Holdings, Inc. • Biological products, (no disgnostic substances)
This Amendment to the 8% Promissory Note (this “Amendment”), dated effective April 11, 2018, is by and between Creative Medical Technology Holdings, Inc., a Nevada corporation (the “Borrower”), and Creative Medical Health, Inc., a Delaware corporation (the “Holder”), The Borrower and Holder will be referred to individually as a “Party” and collectively as the “Parties.” Any capitalized terms not defined in this Amendment will have the meaning set forth in the 8% Promissory Note dated May 18, 2016 issued by the Borrower to the Holder (the “Note”), attached hereto as Exhibit A.
AMENDMENT TO 8% PROMISSORY NOTE8% Promissory Note • April 17th, 2018 • Creative Medical Technology Holdings, Inc. • Biological products, (no disgnostic substances)
This Amendment to the 8% Promissory Note (this “Amendment”), dated effective April 11, 2018, is by, between, and among Creative Medical Technologies, Inc., a Nevada corporation (the “Borrower”), Creative Medical Health, Inc., a Delaware corporation (the “Holder”), and Creative Medical Technology Holdings, Inc. (“CELZ”). The Borrower, Holder, and CELZ will be referred to individually as a “Party” and collectively as the “Parties.” Any capitalized terms not defined in this Amendment will have the meaning set forth in the 8% Promissory Note dated February 2, 2016 issued by the Borrower to the Holder (the “Note”), attached hereto as Exhibit A.
